Skip to main content
. 2015 May 26;10(2):435–444. doi: 10.3892/etm.2015.2520

Table II.

Analysis of risk factors for DR in patients with DM2.

Variable No DR, n (%) DR, n (%) P-value
Gender
  Male 35 (62.50) 73 (60.33) 0.8693
  Female 21 (37.50) 48 (39.66)
Agea
  <50 years 7 (12.50) 17 (14.28) 0.8181
  ≥50 years 49 (87.50) 102 (85.71)
Duration of DM2a
  <15 years 36 (65.45) 58 (48.74) 0.0497
  ≥15 years 19 (34.54) 61 (51.26)
Hypertension
  Yes 36 (64.29) 80 (66.12) 0.8655
  No 20 (35.71) 41 (33.88)
Cataract
  Yes 18 (32.14) 49 (40.50) 0.3204
  No 38 (67.86) 72 (59.50)
Glaucoma
  Yes 3 (5.36) 14 (11.57) 0.2745
  No 53 (94.64) 107 (88.43)
Kidney disease
  Yes 6 (10.71) 26 (21.49) 0.0957
  No 50 (89.29) 95 (78.51)
Insulin therapy
  Yes 9 (16.07) 39 (32.23) 0.0290
  No 47 (83.93) 82 (67.77)
Dyslipidemia
  Yes 33 (58.93) 79 (65.29) 0.5027
  No 23 (41.07) 42 (34.71)
Glycemia
  Yes 44 (78.57) 89 (73.55) 0.5758
  No 12 (21.43) 32 (26.45)
a

Missing data. DR, diabetic retinopathy; DM2, type 2 diabetes mellitus.